Gene · 9113
Papers3,081
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
1,241 to 1,260 of 3,081
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Regulation of MST complexes and activity via SARAH domain modifications. | Biochem Soc Trans | 2021 | 33860801 | PubTator, text mining | PubMed |
| Transcriptional Enhancer Factor Domain Family member 4 Exerts an Oncogenic Role in Hepatocellular Carcinoma by Hippo-Independent Regulation of Heat Shock Protein 70 Family Members. | Hepatol Commun | 2021 | 33860124 | PubTator, text mining | PubMed |
| Malignant pleural mesothelioma co-opts BCL-XL and autophagy to escape apoptosis. | Cell Death Dis | 2021 | 33859162 | PubTator, text mining | PubMed |
| Tenascin-C-mediated suppression of extracellular matrix adhesion force promotes entheseal new bone formation through activation of Hippo signalling in ankylosing spondylitis. | Ann Rheum Dis | 2021 | 33858850 | PubTator, text mining | PubMed |
| Advances in Understanding the LncRNA-Mediated Regulation of the Hippo Pathway in Cancer. | Onco Targets Ther | 2021 | 33854336 | PubTator, text mining | PubMed |
| SKI activates the Hippo pathway via LIMD1 to inhibit cardiac fibroblast activation. | Basic Res Cardiol | 2021 | 33847835 | PubTator, text mining | PubMed |
| SEPT6 drives hepatocellular carcinoma cell proliferation, migration and invasion via the Hippo/YAP signaling pathway. | Int J Oncol | 2021 | 33846777 | PubTator, text mining | PubMed |
| WBP2 negatively regulates the Hippo pathway by competitively binding to WWC3 with LATS1 to promote non-small cell lung cancer progression. | Cell Death Dis | 2021 | 33837178 | PubTator, text mining | PubMed |
| LSD1 as a Biomarker and the Outcome of Its Inhibitors in the Clinical Trial: The Therapy Opportunity in Tumor. | J Oncol | 2021 | 33833800 | PubTator, text mining | PubMed |
| Non-coding RNAs in pancreatic ductal adenocarcinoma: New approaches for better diagnosis and therapy. | Transl Oncol | 2021 | 33831655 | PubTator, text mining | PubMed |
| The m6A RNA methylation regulates oncogenic signaling pathways driving cell malignant transformation and carcinogenesis. | Mol Cancer | 2021 | 33814008 | PubTator, text mining | PubMed |
| Transposon Mutagenesis-Guided CRISPR/Cas9 Screening Strongly Implicates Dysregulation of Hippo/YAP Signaling in Malignant Peripheral Nerve Sheath Tumor Development. | Cancers (Basel) | 2021 | 33808166 | PubTator, text mining | PubMed |
| MicroRNAs Regulating Hippo-YAP Signaling in Liver Cancer. | Biomedicines | 2021 | 33808155 | PubTator, text mining | PubMed |
| NF2 and Canonical Hippo-YAP Pathway Define Distinct Tumor Subsets Characterized by Different Immune Deficiency and Treatment Implications in Human Pleural Mesothelioma. | Cancers (Basel) | 2021 | 33805359 | PubTator, text mining | PubMed |
| LATS1 Is a Mediator of Melanogenesis in Response to Oxidative Stress and Regulator of Melanoma Growth. | Int J Mol Sci | 2021 | 33803640 | PubTator, text mining | PubMed |
| LncRNAs and microRNAs as Essential Regulators of Stemness in Breast Cancer Stem Cells. | Biomolecules | 2021 | 33802575 | PubTator, text mining | PubMed |
| YAP and TAZ Mediators at the Crossroad between Metabolic and Cellular Reprogramming. | Metabolites | 2021 | 33800464 | PubTator, text mining | PubMed |
| Genomic and neoantigen evolution from primary tumor to first metastases in head and neck squamous cell carcinoma. | Oncotarget | 2021 | 33796222 | PubTator, text mining | PubMed |
| Nectin-4 and p95-ErbB2 cooperatively regulate Hippo signaling-dependent SOX2 gene expression, enhancing anchorage-independent T47D cell proliferation. | Sci Rep | 2021 | 33795719 | PubTator, text mining | PubMed |
| The Epigenetic Regulation of Microenvironment in Hepatocellular Carcinoma. | Front Oncol | 2021 | 33791228 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/9113/papers?page=63